| |
Facts and Figures
More than 50 major pharmaceutical, medical device
and other companies are now benefit from rap.IDs products and services.
New products like the particle finder, contract testing service are very
well accepted from the global market.
In the beginning of 2003 rap.ID improves sales and service for the analysis
systems through highgly experienced partners. Rap.ID as well as a
high level of service for its systems are now available in over 10 countries.
With Sci-Tec. Inc in the USA within 5 offices.
In Europe through PMT AG with offices in France,
Italy, Hungary, UK, Belgium, Luxemburg and the Netherlands. In Japan and
Taiwan through Opus1, based in Tokyo. Also we
sell over distributors in: Korea, Israel, India, China and Turkey.
Development of Staff
In the near future the company requires more staff in the sectors marketing
and sales as well as laboratory. |
|
| |
The market
As a cross-section technology of the 21st century, optical
technologies constitute an extraordinarily fast growing market. Procedures,
which provide information quickly by means of exposing material to light
are the key to a fast, contact-free and non-destructive determination
of material composition. Ever smaller material structures and components
as well as stricter production standards call for such an analytical procedure
in a growing number of industrial sectors. And it is exactly this detection
of the chemical composition of particles by means of a spatial resolution,
which is precise to the thousandth of a millimetre, that constitutes the
quantum leap in modern RAMAN microspectroscopy. The universality of this
method, as well as its potential to combine with a powerful chemo-metrical
software open up numerous areas of application for this patented method.
In industrial production, a clean environment is becoming more and more
important. Growth rates for such production facilities show an above-average
increase.
|
|
| |
market potential
Because of the high potential for cost reduction and the increased production
reliability on the part of the user of rap.ID particle analysis systems,
the company expects a fast acceptance in the market. At the same time,
the pressure to rationalize forced on all of the globally operating companies
by mergers, demands a production of ever increasing production yields
at a constantly high quality.
Our Business Activity – Rapid Particle Analysis Systems
In 2002 the company introduced a system for rapid particle analysis in
clean production environments to the market. In an extension of the original
concentration measurement, the system now allows a conclusion about the
material composition and thus about the origin of the particles. Using
the rap.ID technology reacting before a potential malfunction becomes
a possibility, and a proactive quality management can be put into action.
Productivity and the production yield will improve significantly.
It is the core competence of rap.ID to enable the customers to: Know
More Particles!

|
|
| |
Research and Development
Starting Point of Our Success Story
rap.ID constantly invests considerable amounts into research and development.
In 2001 German patent right was granted for the core components of the
particle analysis system. This was an important milestone on the road
to a lasting protection of the companys own products. In order to
expand this position rap.ID will apply for patents on the further development
of several system modules. Therefore in 2003 the patent of the filter
substrate was granted. It is the aim of rap.ID to secure its technological
leadership in this sector.
The application of research to future production scenarios was the main
challenge in order to put our own serial production successfully into
action. Performing Contract Testing after cGLP in 2006 will be the next
step in the direction of a well recognized and reliable future oriented
company working together with pharmaceutical industries. |
|